Chancery Finds Ex-CEO In Contempt In Biopharma IP Suit
A biopharmaceutical company physician-investor was ruled in contempt Wednesday for failing to maintain the Delaware Chancery Court-ordered status quo in a suit challenging his transfer of all intellectual property from a...To view the full article, register now.
Already a subscriber? Click here to view full article